Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.
AI across the pharmaceutical ecosystem. The Illumina Billion Cell Atlas is the first tranche of its program to build a 5 billion cell atlas over three years, and will be the most comprehensive map of ...
Insilico Medicine (“Insilico”), a clinical stage generative artificial intelligence (AI)-driven biotechnology company has recently announced the breakthrough study achieved in collaboration with a ...
Cold Spring Harbor Laboratory's advanced mass spectrometry method enhances sensitivity, facilitating better drug target ...
Demonstrates how dual-purpose therapeutic targets may address both hepatocellular carcinoma progression and cellular ...
Zhongyao Ma, PhD, holds a bachelor’s degree in biology from Shanghai Jiao Tong University and a PhD in genetics and developmental biology from the University of Georgia, U.S. His research focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback